科研之友
微信
新浪微博
Facebook
分享链接
摘要
The right to health protection encourages the Executive to establish a leading health policy according to the principles of equity, quality and citizen participation, to promote a responsible use of drugs and to adopt measures in order to make the provision of pharmaceutical care affordable and with reasonable public health expenditure by the Spanish National Health System as part of the need of optimizing the available resources. Nowadays, the welfare state achieved in our country is progressively more expensive. Hence, in order to guarantee the sustainability of the Spanish National Health System, the Spanish government has promoted a health reform through standards, among others the Royal Decree-Law 16/2012, of April 20, 2012. From this Royal Decree-Law we analyze the impact and the most noteworthy consequences in the pharmaceutical sector.
- 出版日期2013
